Preventing hepatitis C virus recurrence in liver transplant recipients: a role for adoptive immunotherapy?


After liver transplantation in HCV-infected patients, the virus load inevitably exceeds pretransplantation levels. This phenomenon reflects suppression of the host-effector immune responses that control HCV replication by the immunosuppressive drugs used to prevent rejection of the transplanted liver. Here, we describe an adoptive immunotherapy approach… (More)
DOI: 10.1002/hep.23579


1 Figure or Table

Slides referencing similar topics